John P. Pigott, MD, FACS, currently serves as Chief Innovations Officer/Strategic Business Development for ProMedica and ProMedica Innovations, where he works with thought leaders from across the health system to turn ideas into results that generate a measurable impact in the areas of life science technologies, patient outcomes, and new revenue streams. He is also a member of ProMedica’s executive strategy team. Dr. Pigott has designed, developed and implemented recognized and award-winning medical innovations, specifically within the field of vascular surgery. He is the founder and Chief Science Officer for VentureMed Group and Infinity Angioplasty Balloon company, both medical device companies involved in the treatment of peripheral artery disease. He is the author of many articles and presentations, and holds numerous patents, primarily in the life sciences field.
Dr. Pigott is President of the Northwest Ohio Tech Fund II, a Board of Trustees Member for BioOhio, and a Board member of Kapios Health. He is also a former EY Regional Award and National Finalist for Entrepreneur of the Year, a national and international venture capitalist, and a lead developer in establishing the Northwest Ohio ESP and Tech Fund II through the State of Ohio Third Frontier. He has helped to attract more than $50 million to Northwest Ohio, resulting in local job creation and economic development. He also serves as a consultant to numerous multinational medical device companies, conducts national and regional device training programs, and has participated in more than 50 clinical trials.
As a board-certified vascular surgeon at Jobst Vascular Institute (JVI) and ProMedica Toledo Hospital, Dr. Pigott serves as a faculty member of the ACGME-accredited Jobst Vascular Fellowship Program. He is also a clinical professor of surgery at the University of Toledo Medical Center. Dr. Pigott received his medical degree from the Medical College of Ohio, completed his surgical residency at Akron City Hospital, and completed his fellowship in vascular surgery at the Mayo Clinic.